Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1993 Nov 20;307(6915):1308–1311. doi: 10.1136/bmj.307.6915.1308

Reduced childhood mortality after standard measles vaccination at 4-8 months compared with 9-11 months of age.

P Aaby 1, M Andersen 1, M Sodemann 1, M Jakobsen 1, J Gomes 1, M Fernandes 1
PMCID: PMC1679462  PMID: 8257884

Abstract

OBJECTIVE--To evaluate the impact on mortality of standard Schwarz measles immunisation before 9 months of age. DESIGN--Children vaccinated in 1980-3 at 4-5, 6-8, and 9-11 months of age were followed to migration, death, or the age of 5 years. SETTING--One urban district and nine villages in two rural areas of Guinea-Bissau. SUBJECT--307 children vaccinated at 4-8 months and 256 at 9-11 months. MAIN OUTCOME MEASURES--Mortality from 9 months to 5 years of age for children immunised at 4-5, 6-8, and 9-11 months. RESULTS--Mortality was significantly lower in children vaccinated at 6-8 months than at 9-11 months (mortality ratio = 0.63, (95% confidence interval 0.41 to 0.97), p = 0.047). As vaccination was provided in semiannual or annual campaigns it is unlikely that age at vaccination reflected a selection bias. The trend was the same in all three study areas. Improved survival after early immunisation was not related to better protection against measles infection. With a Cox multivariate regression model to adjust for age, sex, season at risk, season at birth, measles infection, and region, children vaccinated at 4-8 months had a mortality ratio of 0.61 (0.40 to 0.92, p = 0.020) compared with children vaccinated at 9-11 months. Reimmunised children tended to have lower mortality than children who received only one vaccine (0.59 (0.28 to 1.27, p = 0.176)). CONCLUSION--Standard measles vaccination before 9 months is not associated with higher childhood mortality than is the currently recommended strategy of immunising from 9 months, and it may reduce mortality. This has implications for measles immunisation strategy in developing countries.

Full text

PDF
1308

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaby P., Bukh J., Hoff G., Leerhøy J., Lisse I. M., Mordhorst C. H., Pedersen I. R. High measles mortality in infancy related to intensity of exposure. J Pediatr. 1986 Jul;109(1):40–44. doi: 10.1016/s0022-3476(86)80569-8. [DOI] [PubMed] [Google Scholar]
  2. Aaby P., Bukh J., Kronborg D., Lisse I. M., da Silva M. C. Delayed excess mortality after exposure to measles during the first six months of life. Am J Epidemiol. 1990 Aug;132(2):211–219. doi: 10.1093/oxfordjournals.aje.a115650. [DOI] [PubMed] [Google Scholar]
  3. Aaby P., Bukh J., Lisse I. M., Smits A. J., Gomes J., Fernandes M. A., Indi F., Soares M. Determinants of measles mortality in a rural area of Guinea-Bissau: crowding, age, and malnutrition. J Trop Pediatr. 1984 Jun;30(3):164–168. doi: 10.1093/tropej/30.3.164. [DOI] [PubMed] [Google Scholar]
  4. Aaby P., Bukh J., Lisse I. M., Smits A. J. Measles mortality, state of nutrition, and family structure: a community study from Guinea-Bissau. J Infect Dis. 1983 Apr;147(4):693–701. doi: 10.1093/infdis/147.4.693. [DOI] [PubMed] [Google Scholar]
  5. Aaby P., Bukh J., Lisse I. M., Smits A. J. Measles vaccination and reduction in child mortality: a community study from Guinea-Bissau. J Infect. 1984 Jan;8(1):13–21. doi: 10.1016/s0163-4453(84)93192-x. [DOI] [PubMed] [Google Scholar]
  6. Aaby P., Clements C. J. Measles immunization research: a review. Bull World Health Organ. 1989;67(4):443–448. [PMC free article] [PubMed] [Google Scholar]
  7. Aaby P., Jensen T. G., Hansen H. L., Kristiansen H., Thårup J., Poulsen A., Sodemann M., Jakobsen M., Knudsen K., Clotilde da Silva M. Trial of high-dose Edmonston-Zagreb measles vaccine in Guinea-Bissau: protective efficacy. Lancet. 1988 Oct 8;2(8615):809–811. doi: 10.1016/s0140-6736(88)92780-8. [DOI] [PubMed] [Google Scholar]
  8. Aaby P., Knudsen K., Jensen T. G., Thårup J., Poulsen A., Sodemann M., da Silva M. C., Whittle H. Measles incidence, vaccine efficacy, and mortality in two urban African areas with high vaccination coverage. J Infect Dis. 1990 Nov;162(5):1043–1048. doi: 10.1093/infdis/162.5.1043. [DOI] [PubMed] [Google Scholar]
  9. Aaby P., Knudsen K., Whittle H., Lisse I. M., Thaarup J., Poulsen A., Sodemann M., Jakobsen M., Brink L., Gansted U. Long-term survival after Edmonston-Zagreb measles vaccination in Guinea-Bissau: increased female mortality rate. J Pediatr. 1993 Jun;122(6):904–908. doi: 10.1016/s0022-3476(09)90015-4. [DOI] [PubMed] [Google Scholar]
  10. Aaby P., Pedersen I. R., Knudsen K., da Silva M. C., Mordhorst C. H., Helm-Petersen N. C., Hansen B. S., Thårup J., Poulsen A., Sodemann M. Child mortality related to seroconversion or lack of seroconversion after measles vaccination. Pediatr Infect Dis J. 1989 Apr;8(4):197–200. [PubMed] [Google Scholar]
  11. Black F. L., Berman L. L., Libel M., Reichelt C. A., Pinheiro F. D., Travassos da Rosa A., Figueira F., Siqueira Gonzales E. Inadequate immunity to measles in children vaccinated at an early age: effect of revaccination. Bull World Health Organ. 1984;62(2):315–319. [PMC free article] [PubMed] [Google Scholar]
  12. Clemens J. D., Stanton B. F., Chakraborty J., Chowdhury S., Rao M. R., Ali M., Zimicki S., Wojtyniak B. Measles vaccination and childhood mortality in rural Bangladesh. Am J Epidemiol. 1988 Dec;128(6):1330–1339. doi: 10.1093/oxfordjournals.aje.a115086. [DOI] [PubMed] [Google Scholar]
  13. Garenne M., Aaby P. Pattern of exposure and measles mortality in Senegal. J Infect Dis. 1990 Jun;161(6):1088–1094. doi: 10.1093/infdis/161.6.1088. [DOI] [PubMed] [Google Scholar]
  14. Hall A. J., Aaby P. Tropical trials and tribulations. Int J Epidemiol. 1990 Dec;19(4):777–781. doi: 10.1093/ije/19.4.777. [DOI] [PubMed] [Google Scholar]
  15. Holt E. A., Boulos R., Halsey N. A., Boulos L. M., Boulos C. Childhood survival in Haiti: protective effect of measles vaccination. Pediatrics. 1990 Feb;85(2):188–194. [PubMed] [Google Scholar]
  16. Hull H. F., Williams P. J., Oldfield F. Measles mortality and vaccine efficacy in rural West Africa. Lancet. 1983 Apr 30;1(8331):972–975. doi: 10.1016/s0140-6736(83)92091-3. [DOI] [PubMed] [Google Scholar]
  17. Markowitz L. E., Sepulveda J., Diaz-Ortega J. L., Valdespino J. L., Albrecht P., Zell E. R., Stewart J., Zarate M. L., Bernier R. H. Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines. N Engl J Med. 1990 Mar 1;322(9):580–587. doi: 10.1056/NEJM199003013220903. [DOI] [PubMed] [Google Scholar]
  18. PETRALLI J. K., MERIGAN T. C., WILBUR J. R. ACTION OF ENDOGENOUS INTERFERON AGAINST VACCINIA INFECTION IN CHILDREN. Lancet. 1965 Aug 28;2(7409):401–405. doi: 10.1016/s0140-6736(65)90755-5. [DOI] [PubMed] [Google Scholar]
  19. Preston N. W. Measles control in young infants. Lancet. 1993 Mar 13;341(8846):688–689. doi: 10.1016/0140-6736(93)90454-o. [DOI] [PubMed] [Google Scholar]
  20. Rooth I., Sinani H. M., Smedman L., Björkman A. A study on malaria infection during the acute stage of measles infection. J Trop Med Hyg. 1991 Jun;94(3):195–198. [PubMed] [Google Scholar]
  21. Rosenthal S. R. Surgery, recall antigens, immunity, and bacillus Calmette-Guerin vaccination. Am J Surg. 1988 Jul;156(1):1–3. doi: 10.1016/s0002-9610(88)80158-2. [DOI] [PubMed] [Google Scholar]
  22. Velema J. P., Alihonou E. M., Gandaho T., Hounye F. H. Childhood mortality among users and non-users of primary health care in a rural west African community. Int J Epidemiol. 1991 Jun;20(2):474–479. doi: 10.1093/ije/20.2.474. [DOI] [PubMed] [Google Scholar]
  23. Whittle H., Hanlon P., O'Neill K., Hanlon L., Marsh V., Jupp E., Aaby P. Trial of high-dose Edmonston-Zagreb measles vaccine in the Gambia: antibody response and side-effects. Lancet. 1988 Oct 8;2(8615):811–814. doi: 10.1016/s0140-6736(88)92781-x. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES